Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
51.45
+0.27 (0.53%)
At close: Jul 16, 2026
Roche Holding AG Revenue
In the year 2025, Roche Holding AG had annual revenue of 63.36B CHF with 1.54% growth. Roche Holding AG had revenue of 31.51B in the half year ending December 31, 2025, with 5.64% growth.
Revenue
63.36B CHF
Revenue Growth
+1.54%
P/S Ratio
4.09
Revenue / Employee
613.62K CHF
Employees
103,249
Market Cap
327.06B USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 63.36B | 961.00M | 1.54% |
| Dec 31, 2024 | 62.40B | 1.95B | 3.23% |
| Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
| Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
| Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 594.41M |
| Vaxart | 255.61M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 148.87M |
| Northwest Biotherapeutics | 1.50M |
| Silence Therapeutics | 839.00K |
| Comjoyful International Company | 564.97K |
Roche Holding AG News
- 1 day ago - Genentech granted priority review for Gazyva sBLA by FDA - TheFly
- 2 days ago - FDA grants Priority Review to Roche's Gazyva/Gazyvaro for adults with primary membranous nephropathy - GlobeNewsWire
- 2 days ago - FDA Grants Priority Review to Genentech's Gazyva for Adults With Primary Membranous Nephropathy - Business Wire
- 3 days ago - Roche introduces cobas Hepatitis D Virus (HDV) test, the first fully automated diagnostic solution to identify the most severe form of viral hepatitis - GlobeNewsWire
- 8 days ago - Roche receives CE Mark for blood test to identify tuberculosis infection - TheFly
- 8 days ago - Roche receives CE Mark for blood test to identify tuberculosis infection - GlobeNewsWire
- 8 days ago - The Market Just Got Shaken—These 3 ETFs May Come Out Stronger - MarketBeat
- 10 days ago - Genentech and Roche Present New Data in Alzheimer's Disease From Across Its Integrated Pharmaceutical and Diagnostics Portfolio at AAIC - Business Wire